Cellularline Balance Sheet Health
Financial Health criteria checks 5/6
Cellularline has a total shareholder equity of €134.7M and total debt of €45.6M, which brings its debt-to-equity ratio to 33.9%. Its total assets and total liabilities are €233.4M and €98.7M respectively. Cellularline's EBIT is €4.1M making its interest coverage ratio 1.5. It has cash and short-term investments of €14.0M.
Key information
33.9%
Debt to equity ratio
€45.63m
Debt
| Interest coverage ratio | 1.5x |
| Cash | €14.04m |
| Equity | €134.66m |
| Total liabilities | €98.75m |
| Total assets | €233.41m |
Recent financial health updates
Is Cellularline (BIT:CELL) Using Too Much Debt?
May 10
Is Cellularline (BIT:CELL) A Risky Investment?
May 25Recent updates
Is Cellularline (BIT:CELL) Using Too Much Debt?
May 10Is Cellularline (BIT:CELL) A Risky Investment?
May 25At €4.58, Is Cellularline S.p.A. (BIT:CELL) Worth Looking At Closely?
Apr 29Some Investors May Be Worried About Cellularline's (BIT:CELL) Returns On Capital
Apr 04Do Institutions Own Cellularline S.p.A. (BIT:CELL) Shares?
Mar 14Does Cellularline's (BIT:CELL) Statutory Profit Adequately Reflect Its Underlying Profit?
Feb 21A Look At The Intrinsic Value Of Cellularline S.p.A. (BIT:CELL)
Feb 06
Is There Now An Opportunity In Cellularline S.p.A. (BIT:CELL)?
Jan 21Should You Buy Cellularline S.p.A. (BIT:CELL) For Its Dividend?
Jan 06Reflecting on Cellularline's (BIT:CELL) Share Price Returns Over The Last Year
Dec 22How Much Of Cellularline S.p.A. (BIT:CELL) Do Insiders Own?
Dec 11Not Many Are Piling Into Cellularline S.p.A. (BIT:CELL) Just Yet
Nov 29Financial Position Analysis
Short Term Liabilities: CELL's short term assets (€126.3M) exceed its short term liabilities (€75.1M).
Long Term Liabilities: CELL's short term assets (€126.3M) exceed its long term liabilities (€23.7M).
Debt to Equity History and Analysis
Debt Level: CELL's net debt to equity ratio (23.5%) is considered satisfactory.
Reducing Debt: CELL's debt to equity ratio has reduced from 34.2% to 33.9% over the past 5 years.
Debt Coverage: CELL's debt is well covered by operating cash flow (28.6%).
Interest Coverage: CELL's interest payments on its debt are not well covered by EBIT (1.5x coverage).